Literature DB >> 686234

Sebaceous carcinoma of the eyelid following radiation therapy.

L B Lemos, D J Santa Cruz, N Baba.   

Abstract

This paper reports a case of a 12-year-old boy with fatal sebaceous carcinoma originating from the eyelid. The carcinoma developed 11 years after curative radiation therapy for bilateral retinoblastoma. Sebaceous carcinomas associated with previous irradiation are uncommon, and only five such cases have been published. Three of the patients were treated for benign disorders and the two other cases followed radiation therapy for bilateral retinoblastoma. Second malignant neoplasms in patients with bilateral retinoblastoma are thought to be related to a genetically inherited predisposition to the development of second malignant tumors. Radiation therapy is claimed to be an inducing factor in many cases but malignant neoplasms are also found in areas distant from the portals of irradiation as well as in patients not irradiated. Most of the secondary tumors were sarcomas, and usually osteogenic sarcomas.

Entities:  

Mesh:

Year:  1978        PMID: 686234     DOI: 10.1097/00000478-197809000-00007

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  4 in total

1.  Sebaceous carcinoma of eyelid.

Authors:  Manoranjan Varshney; Kiran Alam; Mehar Aziz; Veena Maheshwari; Kavita Gaur; SyedAli Raza Rizvi
Journal:  BMJ Case Rep       Date:  2011-06-21

2.  Sebaceous carcinoma of the eyelid: a clinicopathological study.

Authors:  M Zürcher; C R Hintschich; A Garner; C Bunce; J R Collin
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

3.  Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.

Authors:  S Kaliki; A Ayyar; T V Dave; M J Ali; D K Mishra; M N Naik
Journal:  Eye (Lond)       Date:  2015-05-22       Impact factor: 3.775

4.  Early onset sebaceous carcinoma.

Authors:  Dongjin Sung; Sara A Kaltreider; Federico Gonzalez-Fernandez
Journal:  Diagn Pathol       Date:  2011-09-05       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.